**************************************
Thornton KA.
Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University, Baltimore, MD, USA.
CAMBIO DE DISCURSO : ADIÓS A LA SEGUNDA LÍNEA SCLC-ES EN EEUU Y EN EU ...CAMBIAMOS DISCURSO A MANTENIMIENTO EN FIRTS-LINE /// SI NO EXISTIERA IMFORTE ... AHORA MISMO PHARMAMAR ESTARÍA ANTE UNA GRAVE SITUACIÓN /// IMFORTE EN EU DE UN TAM DE 600 MILLONES A UN MERCADO REAL MUCHO MENOR QUE PODRÍA SER DE TAN SOLO UNOS 85 MILLONES /// 2 DE OCTUBRE DE 2028 ... ES LA FECHA PARA LA POSIBLE ENTRADA DE GENÉRICOS DE LURBINECTEDIN ...
10 agosto 2010
The Johns Hopkins University,USA . Yondelis : the evidence for its place in therapy in the treatment of soft tissue sarcoma.
P.D. : En EEUU el posible tratamiento con Yondelis para los Pacientes con Sarcoma ... pasa por conseguir el Aprobado para Cáncer de Ovario
**************************************
Thornton KA.
Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University, Baltimore, MD, USA.
**************************************
Thornton KA.
Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University, Baltimore, MD, USA.
BioSpain 2010 To Showcase International Biotechnology Sector .
... BioSpain 2010 will feature an extensive program of breakout sessions addressing the most relevant topics in the current biotech scenario, including:-- Bioenergy
-- Orphan Drugs & Rare Diseases
-- Alzheimer's and other neurodegenerative diseases: "What is the Spanish industry doing to develop new drugs?"
-- Protein Production & Biosimilars
-- Bioinformatics solutions for genomics: from sequences to Biotechnology and Biomedicine
-- Alternative Equity Market for Growth Companies
-- Venture Capital
-- Biotech's Next Big Thing?
-- Joint Technology Cooperation Projects between Spain and other countries: Eureka & Canadeka
-- International Technology Commercialization: The Challenges of US-European Public-Private Partnerships.
...
Suscribirse a:
Entradas (Atom)